379 related articles for article (PubMed ID: 10690511)
1. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
2. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
3. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of oral lichen planus. A premalignant lesion?
Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
[TBL] [Abstract][Full Text] [Related]
5. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
6. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
[TBL] [Abstract][Full Text] [Related]
8. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx.
Tabor MP; Braakhuis BJ; van der Wal JE; van Diest PJ; Leemans CR; Brakenhoff RH; Kummer JA
J Pathol; 2003 Mar; 199(3):354-60. PubMed ID: 12579537
[TBL] [Abstract][Full Text] [Related]
9. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
11. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
12. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions.
Zhou X; Jordan RC; Li Y; Huang BL; Wong DT
Cancer Genet Cytogenet; 2005 Aug; 161(1):86-9. PubMed ID: 16080964
[TBL] [Abstract][Full Text] [Related]
13. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
16. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
17. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
Gomes CC; Fonseca-Silva T; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in laryngeal cancer.
Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
[TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis.
Roz L; Wu CL; Porter S; Scully C; Speight P; Read A; Sloan P; Thakker N
Cancer Res; 1996 Mar; 56(6):1228-31. PubMed ID: 8640803
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa.
Guo T; Sun JW; Lv QP; Li XG
J Laryngol Otol; 2008 Jan; 122(1):72-7. PubMed ID: 17498326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]